The conference witnessed an overwhelming response, bringing together over 700 attendees, including 150 distinguished speakers, 12 key sponsors, an ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 2025 95 patients enrolled ...

Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along with the discontinuation of its “research ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

"Without careful consideration of the impact of these changes, we risk long-term damage" to medical research, writes Dr. George Weiner.

The stock value and growth potential of a biotech firm depend on the type of diseases it treats. This might also include the research that the firm does as it supports other companies, diseases or ...

Bioprinting offers a host of benefits that researchers continue to explore. It utilizes a combination of living cells, bio-inks, and 3D printing methods to create complex structures like organs or ...